IN DEPTH Running low on comparators: drug shortages in oncology clinical trials ACT EU state of play: EMA’s headway to transform clinical trials CMO Moves: Regulatory catalysts for drug manufacturing-December 2023 Outlook Humira biosimilars set the stage for long-awaited 2023 US launches After much buzz, the entry of Humira biosimilars is being seen as a major cost-cutting opportunity, but market penetration will not be instant R&D Expanding ketamine’s horizons for rare neurological disorders R&D The “Medical Bypass”: New drugs to strike obesity Running low on comparators: drug shortages in oncology clinical trials ACT EU state of play: EMA’s headway to transform clinical trials CMO Moves: Regulatory catalysts for drug manufacturing-December 02/23/2024 23:26:13
Running low on comparators: drug shortages in oncology clinical trials
ACT EU state of play: EMA’s headway to transform clinical trials
CMO Moves: Regulatory catalysts for drug manufacturing-December